Muutke küpsiste eelistusi

E-raamat: Key Account Management Excellence in Pharma & Medtech [Taylor & Francis e-raamat]

Edited by
  • Formaat: 216 pages, 7 Tables, black and white; 51 Line drawings, color; 18 Halftones, color; 69 Illustrations, color
  • Ilmumisaeg: 28-Feb-2022
  • Kirjastus: Routledge
  • ISBN-13: 9781003226512
  • Taylor & Francis e-raamat
  • Hind: 166,18 €*
  • * hind, mis tagab piiramatu üheaegsete kasutajate arvuga ligipääsu piiramatuks ajaks
  • Tavahind: 237,40 €
  • Säästad 30%
  • Formaat: 216 pages, 7 Tables, black and white; 51 Line drawings, color; 18 Halftones, color; 69 Illustrations, color
  • Ilmumisaeg: 28-Feb-2022
  • Kirjastus: Routledge
  • ISBN-13: 9781003226512
"Key Account Management Excellence in Pharma & Medtech is designed to help life sciences practitioners develop and execute innovative and effective key account management (KAM) strategies and capabilities. Pharmaceutical and medtech companies are increasingly pursuing KAM in response to the rapid rise of large, sophisticated and complex healthcare provider and payer systems and groups. Those that invest the time to get KAM right will protect their business and grow with these rising customers. This book is groundbreaking in both its scope and its tailoring of leading KAM practices specifically for life sciences. The central theme is that "key account management is an organization-wide business strategy, not just a role or a sales-specific initiative." KAM is a strategy focused on providing unique offerings and value through an orchestrated, cross-functional, go-to-market model designed specifically to address the needs and engagement preferences of a unique segment of customers. The insights and practices shared in this book are designed to be a valuable reference at every stage of the KAM journey. The book has been designed to facilitate a common language and deep understanding of KAM issues and leading practices organization-wide-particularly for life sciences leaders, account managers and cross-functional team members responsible for building, transforming and supporting their organization's KAM strategies and capabilities"--

Pharmaceutical and medtech companies are increasingly pursuing key account management (KAM) in response to the rise of large, sophisticated and complex healthcare provider and payer systems and groups. Those that invest the time to get KAM right will protect their business and grow with these rising customers, and this book shows you how.

List of figures and tables
xiii
Foreword---A message from the CEO of SAMA xvii
Preface---Important information about this book xxi
Chapter 1 Kam Is A Business Strategy, Not A Role
1(8)
Mike Moorman
Namita Powers
Chapter 2 The Rise Of The Organized Customer And Kam In Healthcare
9(12)
Brian Chapman
Pratap Khedkar
Chapter 3 Where To Play: Key Account Segmentation And Selection
21(20)
Joe Stevens
Jude Konzelmann
Chapter 4 Value Strategy: Evolving From Basic Offerings To Advanced Solutions
41(18)
Joe Stevens
Matt Ruple
Mike Moorman
Chapter 5 Kam Organization Design: Form Follows Function
59(8)
Mike Moorman
Jude Konzelmann
Chapter 6 Executive Alignment And Engagement: It'S Make Or Break For Life Sciences Kam Programs
67(14)
Mike Moorman
Namita Powers
Chapter 7 Kam Program Office: Marshalling The Internal Support Required For Results
81(12)
Mike Moorman
Chapter 8 The Long And Short Of Kam Metrics
93(10)
Mike Moorman
Jude Konzelmann
Namita Powers
Chapter 9 Customer Engagement Process: The Secret To Agile Execution
103(10)
Mike Moorman
Namita Powers
Chapter 10 Bringing Value To Account Planning And Management
113(12)
Namita Powers
Mike Powers
Alex Simon
Chapter 11 Context Is King: Laying The Foundation For A Comprehensive Kam Talent Strategy
125(8)
Tania Lennon
Namita Powers
Bernadette Maher
Chapter 12 The Unique Learning Journey Required For Kam
133(14)
Chris Morgan
Tania Lennon
Namita Powers
Chapter 13 Key Account Manager Incentive Compensation: Aligning To Strategic Objectives
147(16)
Subhashri Suresh
Tobi Laczkowski
Chad Albrecht
Chapter 14 Why Technology Is Critical For Breathing Life Into Kam
163(12)
Ankit Jain
Mike Powers
Pratap Khedkar
Chapter 15 Kam In The United States Versus Europe: Are We Headed To The Same Place?
175(10)
Falko Graf-Meisner
Chris Morgan
Chapter 16 The Future Of Kam In Life Sciences
185(16)
Mike Moorman
Namita Powers
Joe Stevens
Rohan Agni
About the authors 201(8)
Acknowledgments 209(2)
Index 211
Mike Moorman is a Principal at ZS and leads the firms key account management practice. Mike founded ZSs B2B commercial strategy and transformation practice and is a recognized expert in his field. He has worked globally and with more than 50 B2B organizations across 12 industries. Mike serves on the Board of Directors and the Research Advisory Board for the Strategic Account Management Association, and is an Adjunct Lecturer on Sales Strategy at Northwesterns Kellogg Executive Program. Mike has authored more than 60 publications and has been cited in leading publications including Harvard Business Review, Financial Times, The Wall Street Journal, IndustryWeek, USA Today and Selling Power.